Older age, lack of vaccination and infection with variants other than Omicron associated with severity of COVID-19 and in-hospital mortality in Pakistan

Objectives: We investigated factors associated with COVID-19 disease severity and in-hospital mortality in a low-middle income setting. Methods: Records of 197 adult COVID-19 patients admitted to the Aga Khan University Hospital, Karachi between April 2021 and February 2022 were reviewed. Clinical data including, that of SARS-CoV-2 variants was collected. Results: The median age of the patients was 55 years and 51.8% were males. 48.2 % of patients had non-severe disease, while 52.8% had severe/critical disease. Hypertension (48%) and diabetes mellitus (41.3%) were most common comorbid conditions. Omicron (55.3%), Beta (14.7%), Alpha (13.7%), Delta (12.7%) and Gamma (3.6%) were identified in patients. The risk of severe disease was higher in those aged above 50 years (OR 5.73; 95%CI [2.45-13.7]) and in diabetics (OR 4.24; 95% CI[1.82-9.85]). Full vaccination (OR 0.25; 95%CI [0.11-0.58]) or infection with Omicron variants (OR 0.42; 95% CI[0.23-0.74]) reduced disease severity. Age > 50 (OR 5.07; 95%CI [1.92-13.42]) and presence of myocardial infarction (OR 5.11; 95% CI[1.45-17.93]) was associated with increased mortality, but infection with Omicron (OR 0.22 95% CI 0.10-0.53]) reduced risk. Conclusions: Vaccination was found to protect against severe COVID-19 regardless of the infecting variant and is recommended especially, in those aged over 50 years and with co-morbid conditions.

[1]  M. Santillana,et al.  Methods for early characterisation of the severity and dynamics of SARS-CoV-2 variants: a population-based time series analysis in South Africa , 2022, The Lancet Microbe.

[2]  N. Ghanchi,et al.  SARS-CoV-2 Variants of Concern (VOC) Alpha, Beta, Gamma, Delta, and Omicron coincident with consecutive pandemic waves in Pakistan , 2022, medRxiv.

[3]  Mufakhara Fatimah,et al.  Safety and efficacy of Sinopharm vaccine (BBIBP-CorV) in elderly population of Faisalabad district of Pakistan , 2022, Postgraduate medical journal.

[4]  S. Bhatt,et al.  Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study , 2022, The Lancet.

[5]  A. Charlett,et al.  Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection , 2022, The New England journal of medicine.

[6]  Liyuan Liu,et al.  Antibody evasion properties of SARS-CoV-2 Omicron sublineages , 2022, Nature.

[7]  Xiao Chen,et al.  Impact of vaccination on the COVID-19 pandemic in U.S. states , 2022, Scientific Reports.

[8]  J. Bhiman,et al.  Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa , 2021, medRxiv.

[9]  Ezekiel J. Maier,et al.  SARS-CoV-2 Genome-Based Severity Predictions Correspond to Lower qPCR Values and Higher Viral Load , 2021, medRxiv.

[10]  S. A. Haider,et al.  Genomic surveillance reveals the detection of SARS‐CoV‐2 delta, beta, and gamma VOCs during the third wave in Pakistan , 2021, Journal of medical virology.

[11]  S. A. Haider,et al.  Tracking down B.1.351 SARS‐CoV‐2 variant in Pakistan through genomic surveillance , 2021, Journal of medical virology.

[12]  M. A. Syed,et al.  Changing SARS-CoV-2 variants in Karachi, Pakistan from alpha to delta through COVID-19 waves three and four , 2021 .

[13]  B. Souza,et al.  SARS-CoV-2 variant of concern P.1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, Northeast Brazil, February 2021 , 2021, International Journal of Infectious Diseases.

[14]  N. Nasir,et al.  Clinical characteristics and outcomes of COVID-19: Experience at a major tertiary care center in Pakistan. , 2021, Journal of infection in developing countries.

[15]  Samir N. Patel,et al.  COVID-19 Hospitalizations, ICU Admissions and Deaths Associated with the New Variants of Concern , 2021 .

[16]  L. Danon,et al.  Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study , 2021, BMJ.

[17]  J. Nkengasong,et al.  The puzzle of the COVID-19 pandemic in Africa , 2020, Science.

[18]  M. Roser,et al.  Coronavirus Pandemic (COVID-19) , 2020 .

[19]  S. Carmichael,et al.  Variants , 2018, The Works of Aphra Behn.

[20]  Clinical Spectrum of SARS-CoV-2 Infection , 2022 .